severe aat deficiency phenotype pi zz rare condition estimated prevalence individuals spain given low prevalence useful accumulate information derived care patients context spanish registry patients aat deficiency founded NUMBER main objectives establish guidelines adapted country treatment management patients offer expert support physicians country treating patients provide technical support determination pi phenotyping genotyping individuals suspected NUMBER january NUMBER number enrollees increased NUMBER NUMBER NUMBER pi zz cent male NUMBER smokers mean age NUMBER years sd NUMBER years mean fev1 NUMBER predicted sd NUMBER NUMBER index cases compared cases older NUMBER NUMBER vs NUMBER NUMBER years p NUMBER likely smoking history NUMBER vs NUMBER p NUMBER displayed severe impairment pulmonary function fev1 NUMBER NUMBER vs NUMBER NUMBER p NUMBER augmentation therapy administered NUMBER patients NUMBER treated patients severe impairment pulmonary function untreated fev1 NUMBER NUMBER vs NUMBER NUMBER p NUMBER likely index cases NUMBER vs NUMBER p NUMBER characteristics patients included similar described registries registry extended knowledge disease country established local guidelines treatment valid database future international initiatives alpha NUMBER antitrypsin aat deficient aat deficient seventy non index follow operation NUMBER NUMBER